Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single‐Cell Transcriptomics
Human Mutation · 2026-01 · 2026 (1)
DOI: 10.1155/humu/5946608 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Mutation, online erschienen am 15.04.2026. Verfasst von Zhengyou Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China, gxmu.edu.cn. Hauptthemen laut MEDLINE: Proteomics, Pleural Effusion, Biomarkers, Transcriptome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Differential diagnosis of pleural effusion remains challenging despite medical thoracoscopy (MT). We investigated whether integrating proteomic biomarkers with single‐cell transcriptomics and genomic mutation profiling could improve diagnostic accuracy and reveal mechanistic insights.
Methods
We prospectively enrolled 564 patients with pleural effusion undergoing medical thoracoscopy. Pleural fluid biomarkers (adenosine deaminase, carcinoembryonic antigen, cytokeratin‐19 fragment, neuron‐specific enolase) were measured. Single‐cell RNA sequencing profiled immune landscapes across disease etiologies. Driver mutation profiling was performed on malignant pleural effusion samples using targeted next‐generation sequencing encompassing 15 cancer‐related genes. Diagnostic performance was evaluated against histopathological diagnosis.
Results
Final diagnoses included inflammatory PE ( n = 95, 16.8%), tuberculous PE ( n = 299, 53.0%), and malignant PE ( n = 170, 30.1%). For tuberculous PE, ADA achieved AUC 0.916 (sensitivity 83.3% and specificity 89.4%). For malignant PE, combined CEA/CYFRA21‐1 achieved AUC 0.957 (sensitivity 98.2% and specificity 98.7%). Single‐cell analysis revealed distinct immune signatures: Tuberculous PE showed M1 macrophage polarization (M1/M2 ratio 9.48) strongly correlating with ADA levels (rho = 0.68, p < 0.001), whereas malignant PE exhibited immunosuppressive features with elevated M2 macrophages and reduced NK cells. Mutation profiling of malignant PE revealed EGFR (46.5%), TP53 (34.7%), and PIK3CA (8.2%) as the most frequently mutated genes. EGFR‐mutant tumors exhibited significantly higher CEA levels ( p = 0.033) and more immunosuppressive microenvironments with increased M2 macrophages ( p < 0.001) and decreased CD8+ T cells ( p < 0.001). The sequential multibiomarker algorithm achieved 96.5% sensitivity and 98.7% specificity for malignant PE detection, with 85.3% overall three‐way classification accuracy.
Conclusions
Multiomics integration combining proteomic biomarkers with single‐cell immune profiling and genomic mutation characterization achieves high diagnostic accuracy for pleural effusion while revealing disease‐specific immune mechanisms and mutation‐driven therapeutic opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China, gxmu.edu.cn.
- Clinical Science Research Center, The Fourth Affiliated Hospital of Guangxi Medical University, Liuzhou, China, gxmu.edu.cn.
ORCID-Profile: Zhougui Ling, Xiaomou Wei, Moyu Ming
Zitieren
APA
Zhang, Z., Zhan, S., Tang, Y., Ling, Z., Wu, J., Rui, D., Wei, X., & Ming, M. (2026). Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single‐Cell Transcriptomics. Human Mutation, 2026(1). https://doi.org/10.1155/humu/5946608
Vancouver
Zhang Z, Zhan S, Tang Y, Ling Z, Wu J, Rui D, et al. Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single‐Cell Transcriptomics. Human Mutation. 2026;2026(1). doi:10.1155/humu/5946608
BibTeX
@article{Zhang2026,
author = {Zhang, Zhengyou and Zhan, Shaowei and Tang, Ying and Ling, Zhougui and Wu, Jinyan and Rui, Dong and Wei, Xiaomou and Ming, Moyu},
title = {Multiomics Biomarkers for Differential Diagnosis of Pleural Effusion: Integration of Proteomic Markers and Single‐Cell Transcriptomics},
journal = {Human Mutation},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/humu/5946608}
}
EUVIMED